These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 29788226)

  • 1. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness.
    Puzantian H; Akers SR; Oldland G; Javaid K; Miller R; Ge Y; Ansari B; Lee J; Suri A; Hasmath Z; Townsend R; Chirinos JA
    Am J Hypertens; 2018 Aug; 31(9):988-994. PubMed ID: 29788226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.
    Sardana M; Vasim I; Varakantam S; Kewan U; Tariq A; Koppula MR; Syed AA; Beraun M; Drummen NE; Vermeer C; Akers SR; Chirinos JA
    Am J Hypertens; 2017 Feb; 30(2):196-201. PubMed ID: 27927630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population.
    Mayer O; Seidlerová J; Wohlfahrt P; Filipovský J; Vaněk J; Cífková R; Windrichová J; Topolčan O; Knapen MH; Drummen NE; Vermeer C
    J Hum Hypertens; 2016 Jul; 30(7):418-23. PubMed ID: 26016598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K Status, Warfarin Use, and Arterial Stiffness in Heart Failure.
    Hashmath Z; Lee J; Gaddam S; Ansari B; Oldland G; Javaid K; Mustafa A; Vasim I; Akers S; Chirinos JA
    Hypertension; 2019 Feb; 73(2):364-370. PubMed ID: 30580682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.
    Pivin E; Ponte B; Pruijm M; Ackermann D; Guessous I; Ehret G; Liu YP; Drummen NE; Knapen MH; Pechere-Bertschi A; Paccaud F; Mohaupt M; Vermeer C; Staessen JA; Vogt B; Martin PY; Burnier M; Bochud M
    Hypertension; 2015 Jul; 66(1):85-92. PubMed ID: 25987667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients.
    Fain ME; Kapuku GK; Paulson WD; Williams CF; Raed A; Dong Y; Knapen MHJ; Vermeer C; Pollock NK
    Am J Hypertens; 2018 May; 31(6):735-741. PubMed ID: 29635270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies.
    Wei FF; Drummen NE; Schutte AE; Thijs L; Jacobs L; Petit T; Yang WY; Smith W; Zhang ZY; Gu YM; Kuznetsova T; Verhamme P; Allegaert K; Schutte R; Lerut E; Evenepoel P; Vermeer C; Staessen JA
    EBioMedicine; 2016 Feb; 4():162-9. PubMed ID: 26981580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.
    Schurgers LJ; Barreto DV; Barreto FC; Liabeuf S; Renard C; Magdeleyns EJ; Vermeer C; Choukroun G; Massy ZA
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):568-75. PubMed ID: 20133489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
    Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
    J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease.
    Mayer O; Seidlerová J; Bruthans J; Filipovský J; Timoracká K; Vaněk J; Cerná L; Wohlfahrt P; Cífková R; Theuwissen E; Vermeer C
    Atherosclerosis; 2014 Jul; 235(1):162-8. PubMed ID: 24835435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population.
    Wei FF; Trenson S; Thijs L; Huang QF; Zhang ZY; Yang WY; Moliterno P; Allegaert K; Boggia J; Janssens S; Verhamme P; Vermeer C; Staessen JA
    Nephrol Dial Transplant; 2018 Jul; 33(7):1122-1128. PubMed ID: 28992263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension.
    Chirinos JA; Sardana M; Syed AA; Koppula MR; Varakantam S; Vasim I; Oldland HG; Phan TS; Drummen NEA; Vermeer C; Townsend RR; Akers SR; Wei W; Lakatta EG; Fedorova OV
    J Am Soc Hypertens; 2018 Sep; 12(9):681-689. PubMed ID: 30033123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Mayer O; Seidlerová J; Vaněk J; Karnosová P; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Windrichová J; Knapen MH; Drummen NE; Vermeer C
    Int J Cardiol; 2016 Jan; 203():916-22. PubMed ID: 26618253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
    Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
    Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A2.
    Mayer O; Seidlerová J; Vaněk J; Kielbergerová L; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Trefil L; Knapen MH; Drummen NE; Vermeer C
    Maturitas; 2015 Jan; 80(1):82-8. PubMed ID: 25458708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.
    Liabeuf S; Bourron O; Olivier B; Vemeer C; Theuwissen E; Magdeleyns E; Aubert CE; Brazier M; Mentaverri R; Hartemann A; Massy ZA
    Cardiovasc Diabetol; 2014 Apr; 13():85. PubMed ID: 24762216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
    Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
    J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
    Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH
    PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.